• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

北爱尔兰的非苯丙酮尿症高苯丙氨酸血症:常见突变有助于筛查和早期诊断。

Non-phenylketonuria hyperphenylalaninaemia in Northern Ireland: frequent mutation allows screening and early diagnosis.

作者信息

Zschocke J, Graham C A, Stewart F J, Carson D J, Nevin N C

机构信息

Department of Medical Genetics, Belfast City Hospital, Northern Ireland.

出版信息

Hum Mutat. 1994;4(2):114-8. doi: 10.1002/humu.1380040204.

DOI:10.1002/humu.1380040204
PMID:7981714
Abstract

Up to 10% of newborn children with a positive Guthrie test have non-phenylketonuria hyperphenylalaninaemia, i.e., mild elevation of serum phenylalanine that does not require dietary treatment. Depending on the relative frequencies of different phenylalanine hydroxylase mutations in a particular population, non-PKU HPA is usually caused by the combined effect of a mild HPA mutation and a severe PKU mutation. Presented here is a comprehensive analysis of non-PKU HPA in Northern Ireland. Of particular interest is one prevalent HPA mutation (T380M), which is present in over 70% of non-PKU HPA patients in Northern Ireland. Screening for this mutation is easy and inexpensive and can help confirm the diagnosis of non-PKU hyperphenylalaninaemia in the majority of cases at a very early stage. This may be clinically useful and reassuring for the parents. Other mutations described are V245A, L194P, and E390G.

摘要

高达10%的Guthrie试验呈阳性的新生儿患有非苯丙酮尿症高苯丙氨酸血症,即血清苯丙氨酸轻度升高,无需饮食治疗。根据特定人群中不同苯丙氨酸羟化酶突变的相对频率,非苯丙酮尿症高苯丙氨酸血症通常是由轻度高苯丙氨酸血症突变和严重苯丙酮尿症突变的联合作用引起的。本文对北爱尔兰的非苯丙酮尿症高苯丙氨酸血症进行了全面分析。特别值得关注的是一种常见的高苯丙氨酸血症突变(T380M),在北爱尔兰超过70%的非苯丙酮尿症高苯丙氨酸血症患者中存在。对这种突变进行筛查简便且成本低廉,能够在大多数情况下极早期帮助确诊非苯丙酮尿症高苯丙氨酸血症。这对临床可能有用,也能让家长安心。所描述的其他突变有V245A、L194P和E390G。

相似文献

1
Non-phenylketonuria hyperphenylalaninaemia in Northern Ireland: frequent mutation allows screening and early diagnosis.北爱尔兰的非苯丙酮尿症高苯丙氨酸血症:常见突变有助于筛查和早期诊断。
Hum Mutat. 1994;4(2):114-8. doi: 10.1002/humu.1380040204.
2
Two missense mutations causing mild hyperphenylalaninemia associated with DNA haplotype 12.两个错义突变导致与DNA单倍型12相关的轻度高苯丙氨酸血症。
Hum Mutat. 1992;1(2):129-37. doi: 10.1002/humu.1380010208.
3
[Mutation of the phenylalanine hydroxylase gene in the population of central Bohemia. Relation to the clinical picture of phenylketonuria].[波希米亚中部人群中苯丙氨酸羟化酶基因的突变。与苯丙酮尿症临床表现的关系]
Cas Lek Cesk. 1997 May 7;136(9):282-5.
4
Mutation at the phenylalanine hydroxylase gene (PAH) and its use to document population genetic variation: the Quebec experience.苯丙氨酸羟化酶基因(PAH)的突变及其在记录群体遗传变异中的应用:魁北克的经验。
Eur J Hum Genet. 1998 Jan;6(1):61-70. doi: 10.1038/sj.ejhg.5200153.
5
[Did the change of technique of screening investigations influence on improvement of test credibility in recognizing and differentiating diagnostics of hiperphenylalaninemias?].[筛查检查技术的改变是否对提高高苯丙氨酸血症诊断识别和鉴别诊断的检测可信度有影响?]
Przegl Lek. 2009;66(1-2):11-3.
6
Molecular basis of phenylketonuria and a correlation between genotype and phenotype in a heterogeneous southeastern US population.苯丙酮尿症的分子基础以及美国东南部异质人群中基因型与表型的相关性。
Pediatrics. 1996 Apr;97(4):512-6.
7
[Molecular pathology and DNA diagnosis of phenylketonuria and hypermethioninemia].苯丙酮尿症和高甲硫氨酸血症的分子病理学与DNA诊断
Tanpakushitsu Kakusan Koso. 1998 May;43(6):762-9.
8
Extended tetrahydrobiopterin loading test in the diagnosis of cofactor-responsive phenylketonuria: a pilot study.用于诊断辅因子反应性苯丙酮尿症的扩展四氢生物蝶呤负荷试验:一项初步研究。
Mol Genet Metab. 2005 Dec;86 Suppl 1:S91-5. doi: 10.1016/j.ymgme.2005.09.014. Epub 2005 Nov 11.
9
Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.四氢生物蝶呤在治疗母体苯丙酮尿症中的潜在作用。
Pediatrics. 2003 Dec;112(6 Pt 2):1566-9.
10
Eight new mutations of the phenylalanine hydroxylase gene in Italian patients with hyperphenylalaninemia.意大利高苯丙氨酸血症患者苯丙氨酸羟化酶基因的八个新突变
Hum Mutat. 1998;11(3):240-3. doi: 10.1002/(SICI)1098-1004(1998)11:3<240::AID-HUMU9>3.0.CO;2-L.

引用本文的文献

1
Dominant versus recessive: molecular mechanisms in metabolic disease.显性与隐性:代谢性疾病的分子机制
J Inherit Metab Dis. 2008 Oct;31(5):599-618. doi: 10.1007/s10545-008-1016-5. Epub 2008 Oct 21.
2
Rapid single-base mismatch detection in genotyping for phenylketonuria.苯丙酮尿症基因分型中的快速单碱基错配检测
Mol Biotechnol. 2003 Jul;24(3):233-42. doi: 10.1385/MB:24:3:233.
3
A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype.
一项关于苯丙氨酸羟化酶缺乏症的欧洲多中心研究:105种突变的分类及基于基因型预测代谢表型的通用系统
Am J Hum Genet. 1998 Jul;63(1):71-9. doi: 10.1086/301920.
4
Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlations.人类苯丙氨酸羟化酶突变与高苯丙氨酸血症表型:基因型-表型相关性的荟萃分析
Am J Hum Genet. 1997 Dec;61(6):1309-17. doi: 10.1086/301638.
5
PAH deficiency in Italy: correlation of genotype with phenotype in the Sicilian population.意大利的苯丙酮尿症缺乏症:西西里人群中基因型与表型的相关性
J Inherit Metab Dis. 1996;19(1):15-24. doi: 10.1007/BF01799343.
6
Transient neonatal hyperphenylalaninaemia is not related to mutations at the phenylalanine hydroxylase gene.
J Inherit Metab Dis. 1995;18(3):369-70. doi: 10.1007/BF00710439.